drugset / Trial / NCT03297112
Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
Phase 0
Completed
12 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Lantheus Medical Imaging · collabNational Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot clinical trial studies how well contrast-enhanced subharmonic ultrasound imaging works in improving the characterization of adnexal masses in patients undergoing surgery. Contrast-enhanced subharmonic ultrasound imaging uses high-frequency sound waves to produce images of internal organs and when combined with an ultrasound agent such as perflutren lipid microspheres, may help improve imaging and management of adnexal masses.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2018-09-04
- Completion
- 2018-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Definity | Diagnostic / imaging agent | — | Intravenous |